Healthcare Webinars

What is Social Prescribing? Join Social Prescribing USA for the launch of a new quarterly webinar series to learn about how social prescribing utilizes the arts, nature, volunteerism, and local community organizations as medicine for patients of all ages. In this introductory webinar, you will gain an overview of social prescribing, what success has looked like in other countries, and hear testimonials and perspectives from providers, organizers and students contributing to the movement. Attendees will also learn how to join the movement and take action today!Speakers include Alan Siegel, MD (Medical Director and Co-Founder at Social Prescribing USA); Dr. Bogdan Chiva Giurca (Global Alliance & Clinical Champion Lead at the National Academy of Social Prescribing); Hathor-Ra Adwoa (Black Focused Social Prescribing Navigator at Taibu Community Health Centre); Rachel Chen (First-year medical student at Harvard Medical School and Founder of U.S. Social Prescribing Student Collective).

Join us for an insightful session with leading experts in Endourology as we explore the latest innovations in Retrograde Intrarenal Surgery (RIRS). This webinar will highlight the game-changing technologies revolutionizing the field, providing a comprehensive understanding of the tools and techniques available today.With advancements in flexible ureteroscopes, laser lithotripsy, and auxiliary devices, the choice of technology in RIRS can significantly impact outcomes. Our distinguished panel will delve into the criteria for selecting the most effective and appropriate technology based on clinical scenarios, patient factors, and procedural complexities.Whether you are an experienced urologist or someone keen to enhance your knowledge in minimally invasive stone management, this webinar will offer valuable insights into optimizing RIRS practices for improved patient outcomes.Key Learning Objectives:• Understand the latest technological advancements in RIRS.• Learn how to select the appropriate technology based on specific clinical needs.• Explore real-world case studies demonstrating successful RIRS procedures.Speakers:Aminr LAKMICHI | Morroco | ModeratorDaniele CASTELLANI | Italy | ModeratorG. Zeng | China | Topic: Suction SMP vs Suction UASWojciech Krajewski | Polland | Topic: Suction during ECIRS : Does it really help?V. Gauhar | Singapore | Topic: Suction modality in the future : What are my choices ?V.Chandra Mohan | India | Topic: Use of suction sheaths in childrenM. Can KIREMIT | Turkey |Topic: Suction sheaths vs Suction scopes : Which one and why?

This webinar will explore the latest trends in the clinical trial industry, emphasizing direct-to-patient trial strategies and their impact on diversity, equity and inclusion (DEI). Reaching marginalized communities is a critical component for fulfilling study enrollment, yet these communities often face unique challenges.One significant hurdle is the financial burden placed on patients due to the leveraging of patient insurance, which can hinder study enrollment and impact efforts to improve clinical trial diversity in the United States. Current industry trends are centered on patient-centric approaches such as DEI, accelerated start-up timelines and decentralized clinical trials.Prioritizing patient-centricity can significantly enhance patient experience and enrollment, leading to more successful clinical trials. In addition, as clinical trial sites manage numerous studies simultaneously, it is essential to develop supply strategies that simplify the management of investigational medicinal products (IMPs) and non-IMPs (NIMPs).This webinar will dive into how patient-centric supply strategies can address these complexities, improve trial efficiency and support clinical trial diversity. Through case studies, the featured speakers will examine various sourcing options for sponsors, highlighting their benefits and drawbacks for sponsors, patients and sites. Additionally, the discussion will cover how comparator drug supply vendors handle complex trial designs and access to specialty drugs, ensuring that patient needs are met efficiently.Register for this webinar to learn about innovative, on-demand local sourcing solutions, methods to minimize cost and waste in clinical trials and how clinical trial diversity can benefit both sites and patients.Who Should Attend?This webinar will appeal to professionals in the following fields:Vendor Managers/Clinical Vendors ManagerClinical Trial Operations/Supplies Management/Supply ConsultantClinical Trial Comparator Managers/Clinical Trial Sourcing ManagersClinical Supply PlanningStrategy Lead Comparator ManagersClinical Trial ManagersClinical research organisationsWhat You Will LearnAttendees will gain insights into:How direct-to-patient strategies and patient-centric supply chain solutions can enhance clinical trial diversityHow patient centricity can significantly enhance patient experience and enrollmentThe challenges of leveraging patient insurance and how innovative approaches can alleviate financial burdensSpeakers: Samit Bhatt - Vice President, Clinical Trial Patient Solutions, Myonex; Todd Luckritz - Associate Director, Clinical Trial Patient Solutions, Myonex.

This webinar will explore the applications of Dynamic Light Scattering (DLS) and Electrophoretic Light Scattering (ELS) in the pharmaceutical industry. The experts will also discuss how these techniques enhance drug formulation, stability, delivery, and improve the quality and efficacy of pharmaceutical products.Key Takeaways• Understanding the fundamentals of Dynamic Light Scattering (DLS) and Electrophoretic Light Scattering (ELS)• How particle size distribution and zeta potential impact pharmaceutical formulations and stability• Utilizing DLS and ELS to enhance drug delivery systems and improve pharmaceutical quality• Comprehensive understanding of BeNano’s advanced measurement capabilities for pharmaceutical applications.• Real-world case studies demonstrating BeNano’s applications in LNP, proteins, micelles, microemulsions, drug carriers, and Ag nanoparticles.Who Should Attend?This webinar will benefit beginners and professionals in research, development, processing or quality control who acquire understanding of comprehensive pharma characterization or who want to refresh and expand existing knowledge. Furthermore, those who are looking for suggestions for further possible uses of particle size characterization as well as stability of pharmaceutical suspensions should attend this webinar.Speakers: John F. Miller, PhD - Inventor of PALS; Zhibin Guo, MS - Senior Application Scientist.Register now to secure your spot!

Presenter: Dr. Dujeepa Samarasekera, Head of Centre for Medical Education, Yong Loo Lin School of Medicine, National University of Singapore.Interprofessional Education (IPE) is essential in modern medical education, emphasising collaboration among healthcare professionals to improve patient outcomes. Many medical schools have integrated IPE into their curricula with courses, simulations, and clinical rotations, supported by WHO and Interprofessional Collaborative Practice guidelines. In today's volatile, uncertain, complex, and ambiguous world, universities must prepare students for rapidly evolving healthcare environments through interdisciplinary approaches.Join Dr. Samarasekera to learn about the National University of Singapore’s journey and learnings from the introduction of an interdisciplinary curriculum for Dentistry, Medicine, Nursing, and Pharmacy in August 2023.The webinar will be facilitated by Professor Balakrishnan (Kichu) Nair AM.Download flyer for more information about the event and presenter.WHO SHOULD ATTEND?Health professionals and educators who are interested in designing interprofessional educational activities or developing and implementing interprofessional clinical programmes.LEARNING OUTCOMESdiscuss the background of interprofessional education and clarify key conceptual frameworksexplore why interprofessional education may not always lead to effective collaborative practicelearn about conceptual frameworks to design interprofessional education and collaborationREGISTRATIONTickets available via Eventbrite. Click here to register at no cost.ENQUIRIESIf you have any questions regarding the event, please contact:Luciano MeloSenior Program Manager - Research and Journal Management, Education Strategy, Research and EvaluationHETI-HEP@health.nsw.gov.au

During the 2024 Military Family Readiness Academy, we will explore the connection between economic security and family well-being and how to address disparities and challenges.  We’ll look beyond achieving and sustaining positive personal and family financial outcomes by exploring how various conditions affect overall economic security. We’ll delve into underlying factors relating to social dynamics, environmental influences, and community characteristics. We’ll give special focus to how these factors relate to health and wellness as a foundation of economic security.  This webinar will help to empower service providers to leverage their knowledge, skills, and available resources to effectively promote health and well-being.Learning Objectives:• Review the various factors, often called the “social drivers of health,” or SDOH, that influence health and well-being.• Promote a mindset that empowers providers to focus on understanding the root causes of health and wellness challenges and to be change agents for positive outcomes.• Recognize that such a mindset requires a holistic or ecological approach to understanding how underlying contextual factors, individual circumstances, institutions, and programs interact with each other.• Examine how various organizations and institutions are fostering efforts to encourage awareness and action to address health disparities and to promote well-being – with a special focus on the U.S. military and the Cooperative Extension system.• Identify various state and federal programs that can contribute to military family health and wellness, with a special focus on TRICARE, VA health benefits, Medicaid, and Medicare.• Consider possible new programs and policy developments relevant to military family health and well-being.A case story is used throughout the course and webinars in the 2024 Military Family Readiness Academy. This case story provides an opportunity to examine resources and services within the Military Family Readiness System. This family’s example asks service providers to consider the skills they need to support family well-being through the lens of economic security. Read the case story here.Presenters: Christopher Plein and Keith G. Tidball

The Inflation Reduction Act and the resulting Medicare Part D price negotiations are shaping up to be the most far reaching of any event impacting pharma manufacturing in recent history.Although the first set of negotiated prices for selected drugs will not take effect until January 1, 2026, the immediate impact has been fast and furious — more than a dozen lawsuits have been filed by pharmaceutical companies, advocacy groups and the US Chamber of Commerce. Industry media is ablaze with discussions on how price negotiations will impact the pricing of non-selected same-class drugs and biosimilars, as well as future drug development in general.With the first-round negotiated prices for selected drugs to be made public on September 1, 2024, companies are preparing themselves for the second round of selections. This timely webinar will provide an update on:To-date information on the legal actions, existing price negotiations, and market reactionsDrugs likely to be selected for the second round and their same-class competitors who will be impactedThe changes and impact of out-of-pocket costs on enrolleesPrice negotiation benchmarking on selected drugs compared to net pricing on competitorsHow manufacturers should prepare for the overall impact to the industryPart D plan utilization managementRegister for this webinar today to understand the profound impact of the Inflation Reduction Act and Medicare Part D price negotiations on the pharmaceutical industry.Speakers: Mark McCoy, RPh, MBA - Director, Client Engagement Pricing Market Access and Reimbursement, ICON; Amith Shetty, PharmD, RPh - Senior Clinical & Market Access Specialist, ICON; Dr. Xin Zhao - Principal, Global Market Access, ICON.Who Should Attend?This webinar will benefit pharmaceutical and biotech professionals in the following areas:Market access/Marketing/Managed markets/Market researchReal world evidenceRegulatory affairsChannel marketingClinical researchCompetitive intelligenceGovernment affairsHealth economics and outcomes researchWhat You Will LearnAttendees will learn about:The ongoing legal challenges initiated by pharmaceutical companies and other stakeholders against the Inflation Reduction Act’s price negotiation provisionsDrugs likely to be targeted in the upcoming rounds of Medicare Part D price negotiationsThe impact of changes to enrollees and drug manufacturers around reductions in patient out-of-pocket costsThe future impact on Part D plan utilization management

Join us for an informative webinar tailored for healthcare providers interested in understanding and recommending serum tears to their patients. Serum tears, derived from a patient’s own blood, offer a natural and personalized treatment option for chronic dry eye and other ocular surface diseases.Our featured presenter, Dr. Matthew Ward, a leading expert in the industry, will guide you through the science behind serum tears, their therapeutic benefits, and the process of preparing and prescribing them.Dr. Ward will cover:• The benefits of serum tears and the compounding process• The cost-effectiveness of serum tears as a treatment option for patients• The safety of serum tears as opposed to traditional eye drops and solutions• And so much more!This session will equip you with the knowledge and tools to confidently recommend serum tears, offering your patients a cutting-edge solution to manage their eye health.Who Should Attend:• Ophthalmologists• Optometrists• Primary care physicians• Healthcare providers involved in ocular care

There has never been a more exciting and promising time in pharmacological research related to obesity drugs. It is now broadly accepted that obesity is not just a lack of willpower but a complex chronic disease with increased morbidity and mortality that can be managed with the right treatment.Over the past decade or so, gut hormone-based drug development targeting obesity and type 2 diabetes indications and combinations of glucagon-like peptide 1 (GLP1) with other gut hormones (glucose-dependent insulinotropic polypeptide (GIP), glucagon and amylin) as dual or triple agonists or other complementary mode of action have increased rapidly.Semaglutide and, most recently, tirzepatide have demonstrated that a two-digit weight loss at one year is achievable and the Phase II data with retatrutide suggest that 100 percent of patients can now achieve the 5 percent weight loss that was targeted in the past. The next stage in obesity research needs to bring affordable and accessible drugs that can lead to selective fat loss, preservation of lean body mass and long-term weight maintenance. As with many other chronic diseases, combination therapies with complementary modes of action will be required to successfully treat patients with obesity.The objective of this webinar is to discuss the potential next steps in pharmacotherapy targeting obesity. The expert speakers will initially focus on the size of the health burden, the history of drug development and the current pipeline in this indication. They will also focus on the current methodologies to assess body composition. They will discuss the potential additional targets, beyond energy intake, to complement and improve the quality of weight loss and its maintenance, as well as present the methodologies that can be used to assess different components of energy expenditure (EE) and explain the concept of metabolic adaptation and the potential physio-pathological mechanisms involved.Moreover, they will discuss the implications of the changes in EE and metabolic adaptation in long-term weight maintenance. Finally, they will focus on brain imaging and how it can help to understand eating behavior and neurocognitive measures in obesity. The webinar will conclude with the current challenges and mitigation strategies for future clinical trials in obesity.Register for this webinar today to understand the latest advancements related to obesity pharmacotherapy.Speakers: Dr. Eric Ravussin, PhD - Boyd Professor, Douglas L. Gordon Chair in Diabetes and Metabolism, Pennington Biomedical Research Center-LSU System, Baton Rouge, Louisiana; Dr. Claudia Filozof - Vice President and Therapeutic Area Head in Obesity, MASH and Liver Indications, Fortrea; Dr. Peter Alfinito, PhD - Executive Director, Operational Strategy & Planning, Fortrea.Who Should Attend?This webinar is designed for drug developers, healthcare professionals, patient advocacy groups and anyone interested in the advancement of obesity drug development.What You Will LearnAttendees will learn about:Understanding obesity’s health burden and the evolution of drug development in obesityMethodologies used to evaluate body composition in the context of obesity researchPotential additional targets beyond energy intake to enhance weight loss quality and maintenanceCurrent challenges in obesity clinical trials and strategies to mitigate these challenges for future research efforts

Join NACDS President & CEO Steve Anderson and national political analyst Charlie Cook in an exciting virtual NACDS RxIMPACT Votes event to learn more about the 2024 elections and what that might mean for the future of pharmacy.Register to attend this virtual event taking place at 1:00pm ET on September 17 – the celebrated National Voter Registration Day inspiring thousands across the nation to register to vote and participate in the 2024 General Election set for November 5, 2024. You won’t want to miss this insightful election forecast and discussion about the 2024 elections and what this might mean in 2025!Can’t make the event? Register for the event and we will share with you a link to the recording!Elected leaders construct not only the laws by which you live, but the laws by which you are able to serve your patients. They introduce bills, pitch resolutions, and offer amendments. The pharmacy community has seen concrete examples over the years of how Governors, state leaders, and members of the U.S. Congress have played a critical role in the future – and fate – of pro-patient and pro-pharmacy policies and whether they are enacted into law. Those elected in November are key to our community’s policy priorities.Register to Attend this Complementary Zoom Event featuring Charlie CookDate: Tuesday, September 17, 2024, Time: 1:00 PM ETNote: Registering for this event will also subscribe attendees to receive NACDS RxIMPACT emails. Contact Hecker@nacds.org with questions.